{% extends "layout.html" %}
  
{% block title %}Wet Lab{% endblock %}
{% block lead %}This serves as a chronological record of our team's wet lab experimental strategy, documenting our design logic, constructs, and planned validation workflows.{% endblock %}

{% block scroll_nav %}
<nav class="side-scroll-nav scroll-nav" style="font-size: 0.7rem; width: 180px;">
  <span class="side-scroll-nav-label">On This Page</span>
  <a href="#experimental-design">Experimental Design</span></a>
  <a href="#strain-engineering"><span class="highlight-green">Strain Engineering</span></a>
  <a href="#growth-factors"><span class="highlight-green">Recombinant Growth Factors</span></a>
  <a href="#biokernel-validation"><span class="highlight-green">Bayesian Optimisation Validation</span></a>
  <a href="#references">References</span></a>
</nav>
{% endblock %}

{% block page_content %}
<!-- HERO BANNER -->
<div class="education-hero dsp-banner"
     style="background-image: url('https://static.igem.wiki/teams/5916/assets/wetlab-banner.avif');
            background-size: cover;
            background-position: center;
            background-repeat: no-repeat;
            width: 100%;
            height: 300px;
            display: flex;
            align-items: center;
            justify-content: flex-start;
            padding-left: 10%;
            color: white;
            text-align: left;">
  <div class="education-hero-content-container">
    <h1 class="text-glitch">WET LAB</h1>
  </div>
</div>

<div class="spacer5"></div>

<!-- EXPERIMENTAL DESIGN INTRO -->
<div class="page-section width-75" style="margin-left: 220px; margin-bottom: 3rem;" id="experimental-design">
  <h2 style="text-align: left;">
    <span class="animate-text-scramble">Experimental Design</span>
  </h2>

  <p style="text-align: left; margin-bottom: 1.5rem;">
    <strong>We conducted three key experimental lines of work to validate our overall proof of concept:</strong>
  </p>

  <ul style="text-align: left; padding-left: 1.5rem; margin-bottom: 1.5rem;">
    <li>CRISPR/Cas9-based engineering of <strong>EPS-related pathways</strong> to minimise exopolysaccharide production and secretion.</li>
    <li>Production of <strong>recombinant growth factors</strong> in <em>K. phaffii</em> for cultivated meat bioprocessing.</li>
    <li>Validation of a <strong>no-code Bayesian optimisation workflow</strong> using <em>E. coli</em> for pathway tuning and media optimisation.</li>
  </ul>

  <p style="text-align: left; margin-bottom: 1.5rem;">
    These experiments represent three scales of our integrated pipeline — from <strong>strain engineering</strong> and
    <strong>recombinant protein production</strong> to <strong>automation and optimisation</strong>.
  </p>
</div>
<!-- STRAIN ENGINEERING (dropdown) -->
<div class="page-section width-75" style="margin-left: 220px; margin-bottom: 3rem;" id="strain-engineering">
  <h2 style="text-align: left;">
    <span class="highlight-green animate-text-scramble">Strain Engineering of <em>K. phaffii</em></span>
  </h2>

  <details style="margin-top: 1rem; margin-bottom: 2rem;">
    <summary style="cursor: pointer; font-weight: bold;">Show Details</summary>
    <div style="margin-top: 1rem;">

      <p style="text-align: left; margin-bottom: 1.5rem;">
        We designed our engineering strategy to target the most mechanistically plausible causes of
        <strong>exopolysaccharide (EPS) secretion</strong> in <em>K. phaffii</em>, as the exact mechanism remains
        uncharacterised in literature.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Our hypotheses included: (1) the truncated <strong>Hoc1</strong> enzyme causing under-branched glycans and excess free mannans;
        (2) a <strong>cell wall stress response</strong> upregulating mannose secretion; and (3) excessive intracellular mannose production
        driving accumulation of secreted polysaccharides.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        To test these, we selected one protein target for each scenario:
      </p>

      <ul style="text-align: left; padding-left: 1.5rem; margin-bottom: 1.5rem;">
        <li><strong>Hoc1</strong> — 1,6-mannosyltransferase involved in glycan branching.</li>
        <li><strong>PMI</strong> — phosphomannose isomerase, linking glycolysis and GDP-mannose synthesis.</li>
        <li><strong>Rho1</strong> — GTPase in the cell wall integrity pathway, influencing cell rigidity.</li>
      </ul>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Our aim was not to restore full cell wall rigidity, but to mitigate EPS impurity formation while
        maintaining the secretion efficiency that makes <em>K. phaffii</em> a valuable host.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        To implement these modifications, we used the <strong>CRISPR/Cas9</strong> system due to its reliability and modularity.
        However, for scalability, we also evaluated <strong>split-marker integration</strong> as an open, license-free alternative.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Following Gassler et al. (2019)<sup>[1]</sup>, we designed <strong>10 sgRNA devices</strong> flanked by 5′ hammerhead and 3′
        hepatitis delta virus ribozymes for efficient self-excision. Targets were positioned near start and stop codons to
        minimise unintended off-target effects.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        For <strong>Rho1</strong>, we planned a mild overexpression using the weak constitutive promoter <strong>pPGK1</strong>,
        intended to partially restore cell wall integrity without compromising cell growth<sup>[2]</sup>.
      </p>

      <div class="image-aligner-center" style="text-align: center; margin: 2rem 0;">
        <img src="https://static.igem.wiki/teams/5916/wetlab/strainengineering.avif"
             alt="Schematic of strain engineering targets in K. phaffii"
             style="max-width: 45%; border-radius: 0.5rem;" class="tilt-effect">
        <div style="text-align: center; margin-top: 0.5rem; color: #aaa;">
          <em>Figure 1. Overview of genetic engineering strategy targeting <em>Hoc1</em>, <em>PMI</em>, and <em>Rho1</em>.</em>
        </div>
      </div>

      <p style="text-align: left;">
        This experimental framework ensured our edits spanned metabolic, structural, and regulatory pathways,
        maximising the chance of identifying and mitigating the root causes of EPS secretion.
      </p>
    </div>
  </details>
</div>
<!-- RECOMBINANT GROWTH FACTORS (dropdown) -->
<div class="page-section width-75" style="margin-left: 220px; margin-bottom: 3rem;" id="growth-factors">
  <h2 style="text-align: left;">
    <span class="highlight-green animate-text-scramble">Production of Recombinant Growth Factors in <em>K. phaffii</em></span>
  </h2>

  <details style="margin-top: 1rem; margin-bottom: 2rem;">
    <summary style="cursor: pointer; font-weight: bold;">Show Details</summary>
    <div style="margin-top: 1rem;">

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Our growth factor experiment aimed to <strong>demonstrate the ability of <em>K. phaffii</em> to express and secrete 
        mammalian growth factors at high titres</strong>, and to <strong>characterise HGF and IGF-1 expression for the first time in iGEM</strong>.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        We selected <strong>four growth factors</strong> due to their distinct biological properties and relevance to cultivated meat:
      </p>

      <ul style="text-align: left; padding-left: 1.5rem; margin-bottom: 1.5rem;">
        <li><strong>Epidermal Growth Factor (EGF)</strong> — induces mammalian cell proliferation<sup>[3]</sup>.</li>
        <li><strong>Basic Fibroblast Growth Factor (bFGF)</strong> — promotes strong proliferation and migration<sup>[4]</sup>.</li>
        <li><strong>Hepatocyte Growth Factor (HGF)</strong> — activates muscle satellite cells and promotes regeneration<sup>[5]</sup>.</li>
        <li><strong>Insulin-like Growth Factor-1 (IGF-1)</strong> — induces cell proliferation in muscle and bone<sup>[6]</sup>.</li>
      </ul>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Each factor was designed for <strong>secretion</strong> using the <strong>pre-Ost1–pro-α-mating factor hybrid signal</strong>, which 
        enhances ER translocation efficiency and reduces aggregation during secretion.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        The pre-Ost1 signal sequence from <em>S. cerevisiae</em> was chosen based on the work of Barrero et al. (2018),
        who demonstrated up to <strong>20-fold higher secretion</strong> compared to the traditional α-mating factor<sup>[7]</sup>.
      </p>

      <div class="image-aligner-center" style="text-align: center; margin: 2rem 0;">
        <img src="https://static.igem.wiki/teams/5916/wetlab/growthfactors-design.avif"
             alt="Design of recombinant growth factor constructs in K. phaffii"
             style="max-width: 45%; border-radius: 0.5rem;" class="tilt-effect">
        <div style="text-align: center; margin-top: 0.5rem; color: #aaa;">
          <em>Figure 2. Construct design for secretion of recombinant growth factors using the pre-Ost1–pro-α signal.</em>
        </div>
      </div>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        To enable purification, a <strong>C-terminal 6×His-tag</strong> was fused to each construct via a flexible G₄S×₃ linker.
        This facilitates <strong>Ni-NTA affinity chromatography</strong> for downstream purification.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Although His-tags can exhibit immunogenic effects, we justified their use since:
      </p>

      <ul style="text-align: left; padding-left: 1.5rem; margin-bottom: 1.5rem;">
        <li>Our products are intended for <strong>industrial, not therapeutic</strong> use.</li>
        <li>The His-tag offers a <strong>cost-effective and reliable purification</strong> method requiring minimal labour.</li>
      </ul>

      <p style="text-align: left;">
        The final constructs integrate secretion efficiency, structural stability, and downstream compatibility —
        positioning <em>K. phaffii</em> as a feasible host for growth factor production in animal-free media.
      </p>

    </div>
  </details>
</div>
<!-- BAYESIAN OPTIMISATION VALIDATION (dropdown) -->
<div class="page-section width-75" style="margin-left: 220px; margin-bottom: 3rem;" id="biokernel-validation">
  <h2 style="text-align: left;">
    <span class="highlight-green animate-text-scramble">Validating a No-Code Bayesian Optimisation Workflow</span>
  </h2>

  <details style="margin-top: 1rem; margin-bottom: 2rem;">
    <summary style="cursor: pointer; font-weight: bold;">Show Details</summary>
    <div style="margin-top: 1rem;">

      <p style="text-align: left; margin-bottom: 1.5rem;">
        To demonstrate our computational design–wet lab integration, we designed a validation experiment to test the 
        <strong>BioKernel Bayesian optimisation (BO) workflow</strong> using <em>E. coli</em> as a model system. 
        This approach would allow us to assess how BO can efficiently tune enzyme expression levels and inducer concentrations 
        in complex metabolic pathways — paving the way for similar optimisation in <em>K. phaffii</em>.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        The experiment was designed to be both <strong>in silico and in vitro</strong>, combining machine learning–driven prediction 
        with experimental readouts to iteratively improve enzyme ratios for astaxanthin biosynthesis.
      </p>

      <h3 style="text-align: left; margin-top: 1.5rem;">Experimental Setup</h3>
      <p style="text-align: left; margin-bottom: 1.5rem;">
        We utilised the <strong>Marionette-Wild MG1655</strong> strain of <em>E. coli</em><sup>[8]</sup>, which contains twelve orthogonal, 
        small-molecule–inducible sensors to fine-tune transcriptional activity. This system allows precise control over enzyme expression 
        using independent chemical inducers — ideal for an optimisation framework.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        For plasmid construction, we used the <strong>EcoFlex Modular Cloning (MoClo) kit</strong><sup>[9]</sup> developed by the Freemont Lab at Imperial College London. 
        This system provides a Golden Gate–based assembly workflow with RFP negative selection to confirm successful ligation.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        We planned the assembly in three stages:
      </p>

      <ul style="text-align: left; padding-left: 1.5rem; margin-bottom: 1.5rem;">
        <li>Stage 1: 10 transcriptional units, each encoding an enzyme under a unique promoter.</li>
        <li>Stage 2: Two intermediate constructs, each containing five assembled Stage 1 parts.</li>
        <li>Stage 3: A final plasmid combining both Stage 2 assemblies into a single expression vector.</li>
      </ul>

      <div class="image-aligner-center" style="text-align: center; margin: 2rem 0;">
        <img src="https://static.igem.wiki/teams/5916/wetlab/ecoflex-workflow.avif"
             alt="EcoFlex MoClo assembly workflow diagram"
             style="max-width: 45%; border-radius: 0.5rem;" class="tilt-effect">
        <div style="text-align: center; margin-top: 0.5rem; color: #aaa;">
          <em>Figure 3. EcoFlex MoClo assembly workflow used for BioKernel validation experiments.</em>
        </div>
      </div>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        The assembly’s success can be visually verified using colorimetric RFP negative selection — colonies that lose the red phenotype 
        indicate successful Golden Gate assembly.
      </p>

      <h3 style="text-align: left; margin-top: 1.5rem;">Astaxanthin Production Assay</h3>
      <p style="text-align: left; margin-bottom: 1.5rem;">
        The <strong>astaxanthin pathway</strong> was selected as the model biosynthetic circuit, since its product can be quantified colorimetrically 
        at 490 nm without cell lysis — allowing rapid, high-throughput screening in microplates.
      </p>

      <div class="image-aligner-center" style="text-align: center; margin: 2rem 0;">
        <img src="https://static.igem.wiki/teams/5916/wetlab/astaxanthin-diagram.avif"
             alt="Astaxanthin biosynthetic pathway diagram"
             style="max-width: 45%; border-radius: 0.5rem;" class="tilt-effect">
        <div style="text-align: center; margin-top: 0.5rem; color: #aaa;">
          <em>Figure 4. Astaxanthin biosynthetic pathway selected for Bayesian optimisation validation.</em>
        </div>
      </div>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        The experimental workflow involved growing the transformed <em>E. coli</em> cultures in 96-well plates overnight, followed by 
        direct measurement of pigment intensity via absorbance. This setup provides the BO algorithm with measurable fitness feedback.
      </p>

      <p style="text-align: left; margin-bottom: 1.5rem;">
        Although time constraints prevented the physical execution of this experiment, our design establishes a foundation for 
        <strong>data-driven bioprocess optimisation</strong> and demonstrates the feasibility of integrating BioKernel with 
        synthetic biology workflows.
      </p>

      <p style="text-align: left;">
        Future iGEM teams can extend this framework to optimise enzyme balance, growth media, and induction strategies for any 
        recombinant system — bridging computational design and experimental realisation.
      </p>

    </div>
  </details>
</div>
<!-- REFERENCES -->
<div class="page-section width-75" style="margin-left: 220px; margin-bottom: 3rem;" id="references">
  <h2 style="text-align: left;">
    <span class="animate-text-scramble">References</span>
  </h2>

  <ol style="text-align: left; padding-left: 1.5rem; line-height: 1.6;">

    <li>Gassler, T., Heistinger, L., Mattanovich, D., Gasser, B., & Prielhofer, R. (2019). 
      <em>CRISPR/Cas9-mediated homology-directed genome editing in <em>Pichia pastoris</em>.</em> 
      In Gasser & Mattanovich (Eds.), <em>Recombinant Protein Production in Yeast</em>, Methods in Molecular Biology, vol. 1923. 
      Humana Press. https://doi.org/10.1007/978-1-4939-9024-5_9
    </li>

    <li>Xu, S., Zhang, G.Y., Zhang, H., Kitajima, T., Nakanishi, H., & Gao, X.D. (2016). 
      <em>Effects of Rho1, a small GTPase, on the production of recombinant glycoproteins in <em>Saccharomyces cerevisiae</em>.</em> 
      <em>Microbial Cell Factories</em>, 15(1):179. https://doi.org/10.1186/s12934-016-0575-7
    </li>

    <li>Alexander, P., Yuan, L., & Yang, P. (2015). 
      <em>EGF promotes mammalian cell growth by suppressing cellular senescence.</em> 
      <em>Cell Research</em>, 25(1), 135–138. https://doi.org/10.1038/cr.2014.141
    </li>

    <li>Yun, Y.R., Won, J.E., Jeon, E., Lee, S., Kang, W., Jo, H., Jang, J.H., Shin, U.S., & Kim, H.W. (2010). 
      <em>Fibroblast growth factors: biology, function, and application for tissue regeneration.</em> 
      <em>Journal of Tissue Engineering</em>, 2010:218142. https://doi.org/10.4061/2010/218142
    </li>

    <li>Miller, K.J., Thaloor, D., Matteson, S., & Pavlath, G.K. (2000). 
      <em>Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle.</em> 
      <em>American Journal of Physiology–Cell Physiology</em>, 278(1):C174–C181. https://doi.org/10.1152/ajpcell.2000.278.1.C174
    </li>

    <li>Yoshida, T., & Delafontaine, P. (2020). 
      <em>Mechanisms of IGF-1–mediated regulation of skeletal muscle hypertrophy and atrophy.</em> 
      <em>Cells</em>, 9(9):1970. https://doi.org/10.3390/cells9091970
    </li>

    <li>Barrero, J.J., Casler, J.C., Valero, F., Ferrer, P., & Glick, B.S. (2018). 
      <em>An improved secretion signal enhances the secretion of model proteins from <em>Pichia pastoris</em>.</em> 
      <em>Microbial Cell Factories</em>, 17(1):161. https://doi.org/10.1186/s12934-018-1009-5
    </li>

    <li>Meyer, A.J., Segall-Shapiro, T.H., Glassey, E., Zhang, J., & Voigt, C.A. (2019). 
      <em>Escherichia coli “Marionette” strains with 12 highly optimized small-molecule sensors.</em> 
      <em>Nature Chemical Biology</em>, 15(2):196–204. https://doi.org/10.1038/s41589-018-0168-3
    </li>

    <li>Moore, S.J., Lai, H.E., Kelwick, R.J., Chee, S.M., Bell, D.J., Polizzi, K.M., & Freemont, P.S. (2016). 
      <em>EcoFlex: A multifunctional MoClo kit for <em>E. coli</em> synthetic biology.</em> 
      <em>ACS Synthetic Biology</em>, 5(10):1059–1069. https://doi.org/10.1021/acssynbio.6b00031
    </li>

  </ol>
</div>

{% endblock %}